東華大學圖書館 |

Drug repurposing for emerging infectious diseases and cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug repurposing for emerging infectious diseases and cancer/ edited by Ranbir Chander Sobti, Sunil K. Lal, Ramesh K. Goyal.
其他作者:	Sobti, R. C.
出版者:	Singapore :Springer Nature Singapore : : 2023.,
面頁冊數:	xxi, 654 p. :ill., digital ;24 cm.
內容註:	Chapter 1. Drug repurposing: an advance way to traditional drug discovery -- Chapter 2. Drug polypharmacology towards drug repurposing -- Chapter 3. Pharmacovigilance based drug repurposing -- Chapter 4. In silico analysis of cellular interactors of pqbp1 for potential drug repurposing -- Chapter 5. Drug repurposing opportunities in cancer -- Chapter 6. Repurposing of flavonoids as promising phytochemicals for the treatment of lung carcinoma -- Chapter 7. Targeted therapies used in the treatment of non-small cell lung cancer: an overvie -- Chapter 8. Targeting the ubiquitin machinery for cancer therapeutics -- Chapter 9. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 10. Drug repurposing for hematological malignancies -- Chapter 11. Drug repurposing for ent and head and neck infectious and oncologic diseases: current practices and future possibilities -- Chapter 12. Repurposing of immun-modulators for the treatment of cancer with qsar approaches -- Chapter 13. Reverse translational approach in repurposing of drugs for anticancer therapy -- Chapter 14. Therapeutic targeting of antineoplastic drugs in alzheimer's disease: discovered in repurposed agents -- Chapter 15. Repurposing of drugs for the treatment of microbial diseases -- Chapter 16. Repurposing anti-inflammatory agents in the potential treatment of sars-cov-2 infection -- Chapter 17. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 18. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 19. Drug repurposing for covid-19 therapy: pipeline, current status and challenges -- chapter 20. Deoxy-d-glucose - a repurposed drug for covid-19 treatment -- Chapter 21. Repurposing methylene blue for the management of covid-19: prospects, paradox and perspective -- Chapter 22. Drug repurposing in covid-19 and cancer: how far have we come? -- Chapter 23. Repurposing of doxycycline to attenuate influenza virus pathogenesis via inhibition of matrix metalloproteinases in neutrophils -- Chapter 24. Therapeutic repurposing approach: new opportunity for developing drugs against covid‑19 -- chapter 25. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 26. Repurposing of therapeutic approaches for the treatment of vitiligo -- Chapter 27. Emerging infections and their management -- Chapter 28. Repurposing of minocycline, a tetracycline antibiotic, for neurodegenerative disorders.
Contained By:	Springer Nature eBook
標題:	Drug development. -
電子資源:	https://doi.org/10.1007/978-981-19-5399-6
ISBN:	9789811953996

Drug repurposing for emerging infectious diseases and cancer
Drug repurposing for emerging infectious diseases and cancer[electronic resource] /edited by Ranbir Chander Sobti, Sunil K. Lal, Ramesh K. Goyal. - Singapore :Springer Nature Singapore :2023. - xxi, 654 p. :ill., digital ;24 cm.

Chapter 1. Drug repurposing: an advance way to traditional drug discovery -- Chapter 2. Drug polypharmacology towards drug repurposing -- Chapter 3. Pharmacovigilance based drug repurposing -- Chapter 4. In silico analysis of cellular interactors of pqbp1 for potential drug repurposing -- Chapter 5. Drug repurposing opportunities in cancer -- Chapter 6. Repurposing of flavonoids as promising phytochemicals for the treatment of lung carcinoma -- Chapter 7. Targeted therapies used in the treatment of non-small cell lung cancer: an overvie -- Chapter 8. Targeting the ubiquitin machinery for cancer therapeutics -- Chapter 9. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 10. Drug repurposing for hematological malignancies -- Chapter 11. Drug repurposing for ent and head and neck infectious and oncologic diseases: current practices and future possibilities -- Chapter 12. Repurposing of immun-modulators for the treatment of cancer with qsar approaches -- Chapter 13. Reverse translational approach in repurposing of drugs for anticancer therapy -- Chapter 14. Therapeutic targeting of antineoplastic drugs in alzheimer's disease: discovered in repurposed agents -- Chapter 15. Repurposing of drugs for the treatment of microbial diseases -- Chapter 16. Repurposing anti-inflammatory agents in the potential treatment of sars-cov-2 infection -- Chapter 17. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 18. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 19. Drug repurposing for covid-19 therapy: pipeline, current status and challenges -- chapter 20. Deoxy-d-glucose - a repurposed drug for covid-19 treatment -- Chapter 21. Repurposing methylene blue for the management of covid-19: prospects, paradox and perspective -- Chapter 22. Drug repurposing in covid-19 and cancer: how far have we come? -- Chapter 23. Repurposing of doxycycline to attenuate influenza virus pathogenesis via inhibition of matrix metalloproteinases in neutrophils -- Chapter 24. Therapeutic repurposing approach: new opportunity for developing drugs against covid‑19 -- chapter 25. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 26. Repurposing of therapeutic approaches for the treatment of vitiligo -- Chapter 27. Emerging infections and their management -- Chapter 28. Repurposing of minocycline, a tetracycline antibiotic, for neurodegenerative disorders.

This book presents drug repurposing strategies to combat infectious diseases and cancer. It discusses key experimental and in silico approaches for modern drug repositioning, including signature matching, molecular docking, genome-wide associated studies, and network-based approaches aided by artificial intelligence. Further, the book presents various computational and experimental strategies for better understanding disease mechanisms and identify repurposed drug candidates for personalized pharmacotherapy. It also explores the databases for drug repositioning, summarizes the approaches taken for drug repositioning, and highlights and compares their characteristics and challenges. Towards the end, the book discusses challenges and limitations encountered in computational drug repositioning.

ISBN: 9789811953996

Standard No.: 10.1007/978-981-19-5399-6doiSubjects--Topical Terms:

716904
Drug development.

LC Class. No.: RM301.25 / .D78 2023

Dewey Class. No.: 615.19

Drug repurposing for emerging infectious diseases and cancer
LDR:04424nmm a2200325 a 4500 001 2316308
003 DE-He213
005 20230207104140.0
006 m d
007 cr nn 008maaau
008 230902s2023 si s 0 eng d
020 $a 9789811953996 $q (electronic bk.)
020 $a 9789811953989 $q (paper)
024 7 $a 10.1007/978-981-19-5399-6 $2 doi
035 $a 978-981-19-5399-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25 $b .D78 2023
072 7 $a MJC $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MJC $2 thema
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .D794 2023
245 0 0 $a Drug repurposing for emerging infectious diseases and cancer $h [electronic resource] / $c edited by Ranbir Chander Sobti, Sunil K. Lal, Ramesh K. Goyal.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xxi, 654 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Drug repurposing: an advance way to traditional drug discovery -- Chapter 2. Drug polypharmacology towards drug repurposing -- Chapter 3. Pharmacovigilance based drug repurposing -- Chapter 4. In silico analysis of cellular interactors of pqbp1 for potential drug repurposing -- Chapter 5. Drug repurposing opportunities in cancer -- Chapter 6. Repurposing of flavonoids as promising phytochemicals for the treatment of lung carcinoma -- Chapter 7. Targeted therapies used in the treatment of non-small cell lung cancer: an overvie -- Chapter 8. Targeting the ubiquitin machinery for cancer therapeutics -- Chapter 9. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 10. Drug repurposing for hematological malignancies -- Chapter 11. Drug repurposing for ent and head and neck infectious and oncologic diseases: current practices and future possibilities -- Chapter 12. Repurposing of immun-modulators for the treatment of cancer with qsar approaches -- Chapter 13. Reverse translational approach in repurposing of drugs for anticancer therapy -- Chapter 14. Therapeutic targeting of antineoplastic drugs in alzheimer's disease: discovered in repurposed agents -- Chapter 15. Repurposing of drugs for the treatment of microbial diseases -- Chapter 16. Repurposing anti-inflammatory agents in the potential treatment of sars-cov-2 infection -- Chapter 17. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 18. Repurposing of serotonin pathway influencing drugs for potential cancer therapy and antimicrobial functions -- Chapter 19. Drug repurposing for covid-19 therapy: pipeline, current status and challenges -- chapter 20. Deoxy-d-glucose - a repurposed drug for covid-19 treatment -- Chapter 21. Repurposing methylene blue for the management of covid-19: prospects, paradox and perspective -- Chapter 22. Drug repurposing in covid-19 and cancer: how far have we come? -- Chapter 23. Repurposing of doxycycline to attenuate influenza virus pathogenesis via inhibition of matrix metalloproteinases in neutrophils -- Chapter 24. Therapeutic repurposing approach: new opportunity for developing drugs against covid‑19 -- chapter 25. Repurposing drugs for viruses and cancer: a novel drug repositioning strategy for covid-19 -- Chapter 26. Repurposing of therapeutic approaches for the treatment of vitiligo -- Chapter 27. Emerging infections and their management -- Chapter 28. Repurposing of minocycline, a tetracycline antibiotic, for neurodegenerative disorders.
520 $a This book presents drug repurposing strategies to combat infectious diseases and cancer. It discusses key experimental and in silico approaches for modern drug repositioning, including signature matching, molecular docking, genome-wide associated studies, and network-based approaches aided by artificial intelligence. Further, the book presents various computational and experimental strategies for better understanding disease mechanisms and identify repurposed drug candidates for personalized pharmacotherapy. It also explores the databases for drug repositioning, summarizes the approaches taken for drug repositioning, and highlights and compares their characteristics and challenges. Towards the end, the book discusses challenges and limitations encountered in computational drug repositioning.
650 0 $a Drug development. $3 716904
650 0 $a Communicable diseases $x Chemotherapy. $3 670319
650 0 $a Cancer $x Chemotherapy. $3 753516
650 1 4 $a Diseases. $3 618693
650 2 4 $a Therapeutics. $3 680391
650 2 4 $a Pharmacology. $3 634543
650 2 4 $a Oncology. $3 751006
700 1 $a Sobti, R. C. $3 3531208
700 1 $a Lal, Sunil K. $3 1084918
700 1 $a Goyal, Ramesh K. $3 3629477
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-5399-6
950 $a Medicine (SpringerNature-11650)